Symbol="BIOC"
AssetType="Common Stock"
Name="Biocept Inc"
Description="Biocept, Inc., an early stage molecular oncology diagnostic company, develops and markets proprietary circulating tumor cells and circulating tumor nucleic acid assays using a standard blood sample. The company is headquartered in San Diego, California."
CIK="1044378"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SERVICES-MEDICAL LABORATORIES"
Address="9955 MESA RIM ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1381200"
EBITDA="-35215000"
PERatio="None"
PEGRatio="-0.04"
BookValue="15.57"
DividendPerShare="0"
DividendYield="0"
EPS="-69.64"
RevenuePerShareTTM="45.76"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.543"
ReturnOnEquityTTM="-1.877"
RevenueTTM="6586000"
GrossProfitTTM="-2582000"
DilutedEPSTTM="-69.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.966"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.197"
PriceToBookRatio="0.372"
EVToRevenue="0.0893"
EVToEBITDA="-0.336"
Beta="0.818"
num_52WeekHigh="33.6"
num_52WeekLow="0.89"
num_50DayMovingAverage="1.343"
num_200DayMovingAverage="10.86"
SharesOutstanding="1469400"
DividendDate="2020-09-08"
ExDividendDate="None"
symbol="BIOC"
open="0.92"
high="0.94"
low="0.89"
price="0.94"
volume="43049.00"
latest_trading_day="2023-08-18"
previous_close="0.91"
change="0.03"
change_percent="2.8559%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="220830"
Change_recent_avg="-0.04"
Delta_recent_avg="0.27"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-1.99"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_negative_thumbnail_id_2="129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0047.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
